Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1211-1220 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|February 20, 2010
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyJody D Berry, Kevin Hay, James M Rini, et al.
Mabs|September 3, 2016
The underlying inflammatory chronic disease influences infliximab pharmacokineticsChristophe Passot, Denis Mulleman, Theodora Bejan-Angoulvant, et al.
Mabs|September 6, 2016
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activityJenny Calow, Anna-Janina Behrens, Sonja Mader, et al.
Mabs|September 24, 2016
Detection of a phosphorylated glycine-serine linker in an IgG-based fusion proteinOksana Tyshchuk, Hans Rainer Völger, Claudia Ferrara, et al.
Mabs|May 3, 2017
Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidatesMiroslav Dostalek, Thomayant Prueksaritanont, Robert F Kelley
Mabs|April 26, 2017
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanismsClaudia A Castro Jaramillo, Sara Belli, Anne-Christine Cascais, et al.
Mabs|June 6, 2017
Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitisAlain P Vicari, Alain M Schoepfer, Bertrand Meresse, et al.
Mabs|June 7, 2017
Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanningPatrick Koenig, Sarah Sanowar, Chingwei V Lee, et al.
Mabs|August 26, 2016
Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosityJayant Arora, Yue Hu, Reza Esfandiary, et al.
Mabs|June 20, 2018
Antigen recognition by single-domain antibodies: structural latitudes and constraintsKevin A Henry, C Roger MacKenzie
Pageof 178

Showing results (1211-1220 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|February 20, 2010
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyJody D Berry, Kevin Hay, James M Rini, et al.
Mabs|September 3, 2016
The underlying inflammatory chronic disease influences infliximab pharmacokineticsChristophe Passot, Denis Mulleman, Theodora Bejan-Angoulvant, et al.
Mabs|September 6, 2016
Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activityJenny Calow, Anna-Janina Behrens, Sonja Mader, et al.
Mabs|September 24, 2016
Detection of a phosphorylated glycine-serine linker in an IgG-based fusion proteinOksana Tyshchuk, Hans Rainer Völger, Claudia Ferrara, et al.
Mabs|May 3, 2017
Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidatesMiroslav Dostalek, Thomayant Prueksaritanont, Robert F Kelley
Mabs|April 26, 2017
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanismsClaudia A Castro Jaramillo, Sara Belli, Anne-Christine Cascais, et al.
Mabs|June 6, 2017
Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitisAlain P Vicari, Alain M Schoepfer, Bertrand Meresse, et al.
Mabs|June 7, 2017
Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanningPatrick Koenig, Sarah Sanowar, Chingwei V Lee, et al.
Mabs|August 26, 2016
Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosityJayant Arora, Yue Hu, Reza Esfandiary, et al.
Mabs|June 20, 2018
Antigen recognition by single-domain antibodies: structural latitudes and constraintsKevin A Henry, C Roger MacKenzie
Pageof 178